Whole_genome_CRISPR_Cas9_knock_out_screens_in_autologous_tumoroid_T_cell_co_cultures
The goal of this project is to perform genome-wide loss-of-function CRISPR-Cas9 screens across genetically annotated human organoid lines to identify synthetic-lethal interactions between cancer genomes, targeted gene deletions and Autologous reactive T cells.